The importance of diagnostic testing in CLL
Can 7+3 as induction therapy for acute myeloid leukemia (AML) be optimized?
Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine
The significance of FLT3 mutations in AML
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele